J. Martínez Olmos

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis

L. Puig, O. Delgado Sánchez, J. C. Carrascosa Carrillo, 2022, Expert review of pharmacoeconomics & outcomes research.

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

O. Delgado Sánchez, Á. Hidalgo-Vega, J. C. Carrascosa Carrillo, 2022, Acta dermato-venereologica.

[The Spanish experience: a comprehensive approach to HIV and HCV in prisons].

J. Martínez Olmos, M. Gallizo Llamas, 2010, Revista Española de Sanidad Penitenciaria.

[Health related problems as cause of visits to hospital emergency departments].

R. Marín Iglesias, M. I. Baena Parejo, M. J. Faus Dáder, 2005, Medicina clinica.

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain

O. Delgado Sánchez, Á. Hidalgo-Vega, M. Merino, 2023, Frontiers in Public Health.